 |
|
Incidence and predictive factors for recurrent clear cell ovarian carcinoma: results from a single center in Thailand
Wikanda Hemman, Athithan Rattanaburi
Obstet Gynecol Sci. 2022;65(2):188-196. Published online 2022 Feb 23 DOI: https://doi.org/10.5468/ogs.21313
|
|
Citations to this article as recorded by
 Repurposing Drugs in Controlling Recurrent Platinum-Resistant Clear-Cell Ovarian Cancer
Woraporn Sinsuwan, Phawit Norchai, Satish Gandhesiri
Case Reports in Oncological Medicine.2023; 2023: 1. CrossRef Targeted therapies in ovarian cancer: where we stand and where we are heading
Taek Sang Lee
Journal of the Korean Medical Association.2023; 66(6): 384. CrossRef
|